Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Oct 30, 2023
Open Peer Review Period: Oct 30, 2023 - Dec 25, 2023
Date Accepted: Aug 14, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis

Kim M, Vassey J, Li D, Galimov A, Han E, Kirkpatrick MG, Stanton CA, Ozga JE, Lee S, Unger JB

Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis

J Med Internet Res 2024;26:e53938

DOI: 10.2196/53938

PMID: 39446431

PMCID: 11544331

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Discussion of heated tobacco products on Twitter following the IQOS’s Modified-Risk Tobacco Product authorization and US import ban: An observational study

  • Minji Kim; 
  • Julia Vassey; 
  • Dongmei Li; 
  • Artur Galimov; 
  • Eileen Han; 
  • Matthew G Kirkpatrick; 
  • Cassandra A Stanton; 
  • Jenny E Ozga; 
  • Sarah Lee; 
  • Jennifer B Unger

ABSTRACT

Background:

Understanding public opinions about emerging tobacco products is important to inform future interventions and regulatory decisions.

Objective:

We analyzed heated tobacco product (HTP)-related posts on Twitter during the period that included important policy events around IQOS.

Methods:

N=10,454 public English tweets (posted June 2020-December 2021) were collected using HTP-related keywords. We randomly sampled n=2,796 tweets and conducted a content analysis. We used pairwise co-occurrence analyses to evaluate connections across themes.

Results:

Tweet volumes peaked around IQOS-related policy events, such as the US FDA’s modified risk tobacco product (MRTP) authorization (July 2020) or the US import ban (November 2021). Personal testimonials were most common (58% of analytic set), followed by news/information (31%), and marketing/retail (11%). Among the personal testimonials, more tweets were positive (46%) than negative (23%), often comparing the health risks of HTPs to cigarettes. About 10% of the direct marketing/retail tweets raised concerns about cross-border promotions. Neutral testimonials mentioning IQOS brand (44%) and neutral testimonials discussing policy (23%) showed the largest pairwise co-occurrence.

Conclusions:

Results suggest the need for careful communication about the meaning of MRTP authorizations and relative risks of tobacco products. Many tweets expressed HTP-favorable opinions referring to reduced health risks, even though the US FDA has denied marketing of the HTP with reduced risk claims. The popularity of social media as an information source with global reach poses unique challenges in health communication and health policies. While many countries restrict online tobacco marketing, our results suggest that retailers may circumvent such regulations by operating overseas.


 Citation

Please cite as:

Kim M, Vassey J, Li D, Galimov A, Han E, Kirkpatrick MG, Stanton CA, Ozga JE, Lee S, Unger JB

Discussion of Heated Tobacco Products on Twitter Following IQOS’s Modified-Risk Tobacco Product Authorization and US Import Ban: Content Analysis

J Med Internet Res 2024;26:e53938

DOI: 10.2196/53938

PMID: 39446431

PMCID: 11544331

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.